Bri01 0006 01
Brimonidine
Product Images NDC 17478-715
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine (NDC 17478-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bri01 0006 02
Each mL of this ophthalmic solution contains 0.2% of Brimonidine Tartrate and Benzalkonium Chloride (0.005%), acting as a preservative. It is recommended to store the bottle at a controlled room temperature of 20° to 25°C. The solution is manufactured by Akorn, Inc. and is sterile. The usual dosage is one drop in the affected eye(s) three times daily, with approximately 8 hours apart. Additional dosage information can be found in the package insert.*
Bri01 0006 03
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
